Cosmetic cross-reference Noindex: medium evidence

Lentinan

CAS 37339-90-5

Lentinan (CAS 37339-90-5) is a pharmaceutical compound with 0 bioactivity targets and 30 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

30

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Lentinan

CAS Number

37339-90-5

UNII

6751655D1D

ChEMBL ID

CHEMBL2108209

DrugCentral Struct ID

2987

Source Match

DrugCentral (CAS), FDA GSRS (UNII)

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Lentinan used for in pharmaceutical contexts?

Lentinan (CAS 37339-90-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Lentinan?

Lentinan has 30 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Anaemia, Blood lactate dehydrogenase increased, Cardiac failure, Dermatitis, Gamma-glutamyltransferase increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Lentinan also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Lentinus Edodes (Shiitake) Extract with EU status "permitted".

What clinical phase is Lentinan in?

No phase 1-4 clinical development badge is rendered for Lentinan because the matched compound identifier rows do not contain a max-phase value.